Retail sale of pharmaceutical products
FRYDENDAL APOTEK AS
Revenue 2024
NOK 24.6m
Operating profit
NOK 806,000
Equity
NOK 122,000
Incorporated
2021
Employees
14
Share capital
NOK 30,000
Key figures · 2024
Current ratio
1.01
Equity ratio
2.8%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 3.3% | |
| Net margin (%%) | 2.4% | |
| Return on assets (%%) | 18.6% | |
| Likviditet | ||
| Current ratio | 1.01 | |
| Working capital | 45k | |
| Soliditet | ||
| Equity ratio (%%) | 2.8% | |
| Debt-to-equity ratio | 34.46 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.